Group One Trading
HUMA icon

Group One Trading’s Humacyte HUMA Stock Holding History

Group One Trading’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$123K Sell
157,143
-58,333
-27% -$54.1K ﹤0.01% 4672
2026
Q1 		$131K Sell
215,476
-49,121
-19% -$51.1K ﹤0.01% 4481
2025
Q4 		$254K Buy
264,597
+125,124
+90% +$177K ﹤0.01% 4156
2025
Q3 		$243K Buy
139,473
+87,493
+168% +$171K ﹤0.01% 4473
2025
Q2 		$109K Buy
+51,980
New +$99.9K ﹤0.01% 4894
2024
Q4 		– Sell
-55,351
Closed -$274K – 7565
2024
Q3 		$301K Buy
55,351
+22,079
+66% +$146K ﹤0.01% 3265
2024
Q2 		$160K Buy
33,272
+26,627
+401% +$139K ﹤0.01% 3582
2024
Q1 		$20.7K Sell
6,645
-11,710
-64% -$39.4K ﹤0.01% 5388
2023
Q4 		$52.1K Buy
18,355
+3,100
+20% +$7.96K ﹤0.01% 5026
2023
Q3 		$44.7K Buy
15,255
+12,395
+433% +$41K ﹤0.01% 5204
2023
Q2 		$8.18K Buy
+2,860
New +$10.3K ﹤0.01% 6489
2022
Q4 		– Sell
-60,110
Closed -$196K – 7606
2022
Q3 		$196K Buy
60,110
+9,875
+20% +$37.9K ﹤0.01% 4161
2022
Q2 		$161K Buy
50,235
+34,418
+218% +$191K ﹤0.01% 4511
2022
Q1 		$112K Buy
+15,817
New +$92.1K ﹤0.01% 5380
2021
Q4 		– Sell
-6,262
Closed -$61.9K – 8465
2021
Q3 		$73K Buy
+6,262
New +$71.6K ﹤0.01% 6219

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Group One Trading's HUMA Position: Q2 2026 in Review

Group One Trading reduced its Humacyte (HUMA) stake by 27% in Q2 2026, selling an estimated $54.1K and leaving 157,143 shares worth $123K. The position accounts for ﹤0.01% of the portfolio, ranked #4672.

Group One Trading first reported a position in HUMA in Q3 2021 and has held it in 15 quarters since. The position peaked at $301K in Q3 2024. 161 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • Group One Trading held 157,143 shares of Humacyte worth $123K as of Q2 2026.
  • Group One Trading sold 58,333 Humacyte shares in Q2 2026, an estimated $54.1K.
  • Humacyte made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #4672 holding.
  • Group One Trading first reported a position in Humacyte in Q3 2021 and has held it in 15 quarters since.
  • Group One Trading's Humacyte position peaked at $301K in Q3 2024.
  • 161 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.